netFormulary NHS
Birmingham, Sandwell, Solihull and environs APC Formulary
Maintained by Midlands and Lancashire Commissioning Support Unit
 Search
 Formulary Chapter 26: A5 - Wound management products and elasticated garments - Full Chapter
Notes:

 Please note: silk garments are non-formulary

Chapter Links...
 Details...
A5.01.02  Expand sub section  Absorbent dressings
A5.01.02  Expand sub section  For lightly exuding wounds
A5.01.02  Expand sub section  For moderately to heavily exuding wounds
A5.01.02  Expand sub section  For heavily exuding wounds
Eclypse
View adult BNF View SPC online View childrens BNF
Formulary
Green

Approved June 2018 to replace Flivasorb®

 
   
KerraMaxCare
View adult BNF View SPC online View childrens BNF
Formulary
Red
Superabsorbent dressing
Type of wound product is suitable for
Highly exuding wounds as a primary or secondary dressing. Can be used under compression therapy
Stackable as no backing present to hold exudate

Duration dressing remains on wound before changing
1-7 days.
Frequency of dressing change
Dependent on level of exudate, usually daily or more frequently
Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
Do not cut or tear
Rationale for inclusion in formulary
Required for heavily exuding wounds. Hospital Use Only
 
   
 ....
 Non Formulary Items
Flivasorb

View adult BNF View SPC online View childrens BNF
Non Formulary
Black

Superabsorbent dressing
Alternative to KerraMaxCare if patient discharged form hospital with.
Type of wound product is suitable for
For heavily exuding wounds
Can be used under compression bandages
Secondary Dressing Only
Duration dressing remains on wound before changing
Up to 7 days
Frequency of dressing change
When exudate levels determine
Caution/contraindications (when not to use the dressing, patient groups to avoid etc.)
Known sensitivity to any components of the dressing
Lightly exuding wounds
Must not be cut or torn
Rationale for inclusion in formulary
Management of heavily exuding wounds. Cost effective.
Must be applied white side to the wound bed.

 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Prescribing in children

The APC notes that the informed use of unlicensed medicines or of licensed medicines for unlicensed applications (‘off-label’ use) is often necessary in paediatric practice.

The APC advises GPs to consider specialist prescribing recommendations for Green and Amber medicines that are not subject to ESCAs or RICaDs in combination with the information provided in the BNFC which goes beyond that of marketing authorisations. The BNFC has been designed for rapid reference and the information presented has been carefully selected to aid decisions on prescribing.

  

Green

Medicines which are suitable for initiation and maintenance prescribing by primary and secondary care clinicians. These medicines should be initiated and prescribed within their licensed indications.  

Amber

Initiation and maintenance of prescribing by Specialists and transfer to Primary Care prescribing when appropriate, or initiation and maintenance of prescribing in Primary Care following recommendation from a Specialist.

Some amber medicines require agreement with the local (internal) medicines committee prior to initiation; others may require a framework to support safe transfer and maintenance of care such as a RICaD or ESCA. The Formulary will be annotated to reflect these requirements.   

Red

Medicines for initiation and maintenance prescribing by Specialists only  

Black

Non-formulary medicines- medicines not recommended for routine primary care prescribing.  

Grey

Positive NICE TA and /or awaiting local clarification on place in therapy ; Please contact your Medicines Optimisation team for more information.  

netFormulary